Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024
Compare Balance Sheet Results of Onyx Biotec
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
18.13
23.71
-5.58
-23.53%
Share Warrants & Outstandings
Total Reserve
37.49
0.95
36.54
3,846.32%
Shareholder's Funds
55.62
24.65
30.97
125.64%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.76
0.00
6.76
0.00%
Secured Loans
5.49
0.00
5.49
0.00%
Unsecured Loans
1.27
0.00
1.27
0.00%
Deferred Tax Assets / Liabilities
3.14
0.00
3.14
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
9.90
0.00
9.90
0.00%
Current Liabilities
Trade Payables
16.73
0.00
16.73
0.00%
Other Current Liabilities
3.30
0.14
3.16
2,257.14%
Short Term Borrowings
5.70
0.44
5.26
1,195.45%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
25.73
0.57
25.16
4,414.04%
Total Liabilities
91.25
25.23
66.02
261.67%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
40.90
0.05
40.85
81,700.00%
Less: Accumulated Depreciation
0.00
0.01
-0.01
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
40.90
0.04
40.86
102,150.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.02
-0.02
-100.00%
Other Non Current Assets
1.16
0.00
1.16
0.00%
Total Non-Current Assets
42.06
0.07
41.99
59,985.71%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
16.10
0.00
16.10
0.00%
Sundry Debtors
20.23
0.60
19.63
3,271.67%
Cash and Bank
8.61
21.30
-12.69
-59.58%
Other Current Assets
4.07
0.00
4.07
0.00%
Short Term Loans and Advances
0.17
3.26
-3.09
-94.79%
Total Current Assets
49.19
25.16
24.03
95.51%
Net Current Assets (Including Current Investments)
23.46
24.59
-1.13
-4.60%
Total Current Assets Excluding Current Investments
49.19
25.16
24.03
95.51%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
91.25
25.23
66.02
261.67%
Contingent Liabilities
0.00
0.49
-0.49
-100.00%
Total Debt
12.46
0.44
12.02
2,731.82%
Book Value per share (adjusted)
30.68
10.40
20.28
195.00%
Annual - Borrowings
Borrowings 12.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 40.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 49.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024






